| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/03/2000 | WO2000005235A1 Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical preparations containing same, method for producing same and their use in magnetic resonance imaging of necrosis and infarction |
| 02/03/2000 | WO2000004868A2 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | DE19835082A1 Paramagnetische 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung für das Nekrose- und Infarkt-MR-Imaging Paramagnetic 3-, 8-substituted Deuteroporphyrinderivate, pharmaceutical compositions containing them, processes for their preparation and their use for necrosis and infarction imaging MR |
| 02/03/2000 | DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use |
| 02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |
| 02/02/2000 | EP0977049A1 PROCESS FOR OBTAINING IMAGES AND SPECTRA OF THE EXTRACELLULAR pH BY MAGNETIC RESONANCE WITH EXTRINSINC INDICATORS CONTAINING 1H OR 19F |
| 02/02/2000 | EP0975670A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy |
| 02/02/2000 | EP0975669A1 Calcitonin receptor-binding peptides |
| 02/02/2000 | EP0975651A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 02/02/2000 | EP0975580A1 Contrast agent preparation |
| 02/02/2000 | EP0975374A1 Radiometal-binding peptide analogues |
| 02/02/2000 | EP0975372A1 Contrast media for imaging of lung draining lymph nodes, administered through the lungs |
| 02/02/2000 | EP0774970A4 Method of using hyaluronic acid for the detection, location and diagnosis of tumors |
| 02/02/2000 | EP0664714B1 Mr imaging compositions, based on poly(alkyleneoxide) |
| 02/02/2000 | EP0314764B2 Injectable opacifying liposome composition |
| 02/01/2000 | US6020485 Process for producing tetraazabicyclo monoacetic acid |
| 02/01/2000 | US6020145 Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96 |
| 02/01/2000 | US6020123 Oligonucleotide sequences for the amplification of the genome of the retroviruses of the HIV-2 and SIV type, and their uses for in vitro diagnosis of the infections due to these viruses |
| 02/01/2000 | US6019960 Systems for harmonic ultrasound imaging |
| 02/01/2000 | US6019959 Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO1999063115A3 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/26/2000 | EP0974367A1 The use of a vital dye for facilitating surgical procedures for vitreo-retinal surgery |
| 01/26/2000 | EP0973740A1 Design, synthesis and use of specific polyamide dna-binding ligands |
| 01/26/2000 | EP0973554A1 Chelating agents |
| 01/26/2000 | EP0973553A2 Blood-pool carrier for lipophilic imaging agents |
| 01/26/2000 | EP0973552A2 Improvements in or relating to diagnostic/therapeutic agents |
| 01/26/2000 | EP0841854A4 Novel compositions for use in embolizing blood vessels |
| 01/26/2000 | EP0758895B1 Sublingual dosage forms containing apomorphine for use in the treatment of erectile dysfunction |
| 01/25/2000 | US6018678 Collecting analyte to be measured in blood or lymph sample |
| 01/25/2000 | US6018098 Screening suppressors by applying to skin of transgenic mouse capable of expressing a reporter gene regulated by human elastin promoter, exposing mouse to 8-methoxypsoralen then ultraviolet a radiation, measuring gene expression |
| 01/25/2000 | US6018097 Transgenic mice expressing human insulin |
| 01/25/2000 | US6017977 Methods for embolizing blood vessels |
| 01/25/2000 | US6017514 Contacting a labeled antibody specific to an internal cell component but not with external ones with tissue of a mammal that has received therapy to kill malignant cells; measuring the binding where the internal component is an antigen |
| 01/25/2000 | US6017310 Use of hollow microcapsules |
| 01/20/2000 | WO2000002588A1 Targeted site specific drug delivery compositions and method of use |
| 01/20/2000 | WO2000002587A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/20/2000 | WO2000002584A2 Cancer treatment methods using antibodies to aminophospholipids |
| 01/20/2000 | WO1999025389A3 Magnetic resonance imaging agents for the detection of physiological agents |
| 01/20/2000 | WO1998057666A8 Use of acousto-optical and sonoluminescence contrast agents |
| 01/20/2000 | CA2331789A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/19/2000 | EP0972527A2 Contrast agents containing carbohydrate particles and a surfactant |
| 01/19/2000 | EP0972526A2 Preparation of diagnostic agents |
| 01/19/2000 | EP0972013A1 Tissue specific promoters |
| 01/19/2000 | EP0971747A2 Contrast agents |
| 01/19/2000 | EP0971692A2 Specific magnetosome, method for the production and use thereof |
| 01/19/2000 | EP0971677A1 Bone cement and method of preparation |
| 01/19/2000 | EP0890066A4 Cryogenic accumulator for spin-polarized xenon-129 |
| 01/19/2000 | EP0847240A4 Novel embolizing compositions |
| 01/19/2000 | EP0843560A4 Cellulose diacetate compositions for use in embolizing blood vessels |
| 01/19/2000 | EP0664713B1 Therapeutic and diagnostic imaging compositions and methods |
| 01/19/2000 | CN1048410C Contrast medium and its producing method |
| 01/18/2000 | US6015904 Stable reagents for the preparation of radio pharmaceuticals |
| 01/18/2000 | US6015561 Antigen binding peptides (abtides) from peptide libraries |
| 01/18/2000 | US6015546 Atomizing a solution or dispersion of protein wall forming material |
| 01/18/2000 | US6015545 Manganese, vitamin d and amino acids for magnetic resonance imaging and medical diagnosis |
| 01/18/2000 | US6015541 Radioactive embolizing compositions |
| 01/18/2000 | CA2010588C Substituted pyrimidine derivatives, their uses and a process for the preparation thereof |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001805A1 Cells and animals deficient in protein kinase c epsilon |
| 01/13/2000 | WO2000001733A1 Amides of hyaluronic acid and the derivatives thereof and a process for their preparation |
| 01/13/2000 | WO2000001663A1 Novel fluorescent lanthanide chelates |
| 01/13/2000 | WO2000001414A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | WO2000001413A1 Intracellular sensitizers for sonodynamic therapy |
| 01/13/2000 | WO2000001350A2 Material for modifying the optical properties of different cells, device for applying such a material, diagnostic apparatus for determining the optical properties of cells and device for irradiating cells |
| 01/13/2000 | WO2000001342A1 Vascular embolizing compositions comprising ethyl lactate and methods for their use |
| 01/13/2000 | WO1999049716A3 Method for producing liposomal formulations of active agents by high-pressure homogenisation |
| 01/13/2000 | WO1999046367A8 Methods of diagnosis and triage using cell activation measures |
| 01/13/2000 | WO1999036104A3 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these |
| 01/13/2000 | WO1999030745A3 Dota-biotin derivatives |
| 01/13/2000 | CA2336904A1 Novel fluorescent lanthanide chelates |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336134A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | CA2335808A1 Intracellular sensitizers for sonodynamic therapy |
| 01/13/2000 | CA2335113A1 Material for modifying the optical properties of different cells, device for applying such a material, diagnostic apparatus for determining the optical properties of cells and device for irradiating cells |
| 01/13/2000 | CA2335043A1 Vascular embolizing compositions comprising ethyl lactate and methods for their use |
| 01/12/2000 | EP0970113A1 Novel monomer elements for marking peptidic nucleic acids |
| 01/12/2000 | EP0969879A2 THE USE OF MONONUCLEAR PHAGOCYTES IN $i(IN VIVO) IMAGING OF HYPOXIC/ISCHAEMIC TISSUE |
| 01/12/2000 | EP0969878A1 Method for detecting abnormal epithelial cell shedding |
| 01/12/2000 | EP0969855A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 01/12/2000 | EP0805983B1 Process and compounds for the magnetorelaxometric detection of analytes and use thereof |
| 01/12/2000 | CN1241212A Compound and methods for immunotherapy and diagnosis of tuberculosis |
| 01/11/2000 | US6013858 Mouse lacking heart-muscle adenine nucleotide translocator protein and methods |
| 01/11/2000 | US6013810 Free radicals |
| 01/11/2000 | US6013527 Preservative mixture for diagnostic test liquids |
| 01/11/2000 | US6013243 Gaseous inhalable ultrasound contrast agents and method therefor |
| 01/11/2000 | US6013241 Use of porphyrin-complex or expanded porphyrin-complex compounds as an infarction localization diagnosticum |
| 01/06/2000 | WO2000000636A2 In vivo determination of metabolic function for use in therapy management |
| 01/06/2000 | WO1999056723A3 Hemoglobine-haptoglobin complexes for targeted drug delivery |
| 01/06/2000 | CA2335616A1 In vivo determination of metabolic function for use in therapy management |
| 01/05/2000 | EP0968186A1 Improved polyamides for binding in the minor groove of double stranded dna |
| 01/05/2000 | EP0968173A1 Process for the preparation of iodinated contrast agents and intermediates therefor |
| 01/05/2000 | EP0968013A1 Coated implantable medical device |
| 01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 01/05/2000 | EP0968000A1 Administrable compositions and methods for magnetic resonance imaging |
| 01/05/2000 | EP0871637A4 Tungsten clusters |
| 01/05/2000 | EP0760683B1 Bile acid conjugates, derivatives thereof with metal complexes and related uses |
| 01/05/2000 | CN1240479A Truncated soluble tumor necrosis factor type-I and type-II receptors |